Based on the Target Healthcare REIT Ltd stock forecast from 0 analysts, the average analyst target price for Target Healthcare REIT Ltd is not available over the next 12 months. Target Healthcare REIT Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Target Healthcare REIT Ltd is Slightly Bullish , which is based on 6 positive signals and 3 negative signals. At the last closing, Target Healthcare REIT Ltd’s stock price was GBX 75.70. Target Healthcare REIT Ltd’s stock price has changed by -1.05% over the past week, -8.13% over the past month and +0.80% over the last year.
No recent analyst target price found for Target Healthcare REIT Ltd
No recent average analyst rating found for Target Healthcare REIT Ltd
Company Overview Target Healthcare REIT Ltd
UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes. The Group's portfolio at 31 December 2023 comprised 98 assets let to 32 tenants with a total value of £911.1 million. The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors. Read Less
UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpos...Read More
Frequently Asked Questions About Target Healthcare REIT Ltd (THRL:LSE) Stock
Stock Target Advisor's fundamental analysis for Target Healthcare REIT Ltd's stock is Slightly Bullish .
THRL:LSE stock's dividend yield is 6.98%.
Our analysis grades THRL:LSE stock's dividend yield at F. This means that THRL:LSE stock's dividend yield is above 20% of the stocks in the REIT - Healthcare Facilities sector in the LSE exchange.
Based on this THRL:LSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on THRL:LSE's stock to indicate what its average analyst target is.
THRL:LSE stock's Price/Earning ratio is 9.36.
Our analysis grades THRL:LSE stock's Price / Earning ratio at C. This means that THRL:LSE stock's Price/Earning ratio is above 25% of the stocks in the REIT - Healthcare Facilities sector in the LSE exchange.
Based on this THRL:LSE may be undervalued for its sector.
The last closing price of THRL:LSE's stock was GBX 75.70.
The most recent market capitalization for THRL:LSE is GBX 0.53B.
Unfortunately we do not have enough analyst data on THRL:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Target Healthcare REIT Ltd's stock.
As per our most recent records Target Healthcare REIT Ltd has 0 Employees.
Target Healthcare REIT Ltd's registered address is Level 4 Dashwood House, London, United Kingdom, EC2M 1QS.
You can get more information about it from Target Healthcare REIT Ltd's website at https://www.targethealthcarereit.co.uk.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for THRL:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
